Dyadic Yoga Program for Lung Cancer Patients and Caregivers
This study is testing a mobile app that delivers an unsupervised yoga program for people with non-small cell lung cancer who are receiving radiation therapy to the chest (thoracic radiotherapy) and their family caregivers. The goal is to see how easy the app is to use, if it's practical for people to participate, and if they find it acceptable. The study will involve about 60 participants in total. You might be able to join if you have non-small cell lung cancer and are getting at least 24 radiation treatments, have a good physical ability (ECOG performance status of <2), and have a family caregiver who is willing to participate with you. Both you and your caregiver must be over 18 years old. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study that will enroll about 60 participants. It aims to test an app-based yoga program.
- What's involved
- Participants will complete one 60-minute "Thinking out Loud Session" with a yoga therapist, either in person or via Zoom. The study also includes pre- and post-intervention assessments of physical function and quality of life, along with semi-structured interviews.
- Compensation
- Not stated in the trial record.
- Follow-up
- Safety and adverse events will be measured through study completion, which is an average of 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kathrin Milbury, MA,PHD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Safety and Adverse Events (AEs)Through study completion; an average of 1 year.
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0